Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 1,025,455 |
|
|||||
| News | - | ||||||
| Day High | 0.709 | Low High |
|||||
| Day Low | 0.6603 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Vaxart Inc | VXRT | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.04345 | 6.60% | 0.70185 | 15:08:37 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.6985 | 0.6603 | 0.709 | 0.6584 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,838 | 1,025,455 | $ 0.6849552 | $ 702,391 | - | 0.53 - 1.59 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 15:08:37 | 89 | $ 0.703 | USD |
Vaxart Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 119.96M | 173.86M | - | 7.38M | -82.47M | -0.47 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Vaxart News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical VXRT Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.82 | 0.8568 | 0.6331 | 0.7218726 | 1,560,934 | -0.11815 | -14.41% |
| 1 Month | 1.33 | 1.34 | 0.6331 | 0.9709773 | 1,657,447 | -0.62815 | -47.23% |
| 3 Months | 1.20 | 1.54 | 0.6331 | 1.15 | 1,721,431 | -0.49815 | -41.51% |
| 6 Months | 0.6341 | 1.54 | 0.53 | 0.9854986 | 1,510,529 | 0.06775 | 10.68% |
| 1 Year | 0.73 | 1.59 | 0.53 | 0.9514277 | 1,555,231 | -0.02815 | -3.86% |
| 3 Years | 5.68 | 11.108 | 0.53 | 5.76 | 4,002,974 | -4.98 | -87.64% |
| 5 Years | 0.6816 | 24.90 | 0.2543 | 6.72 | 6,435,825 | 0.02025 | 2.97% |
Vaxart Description
| Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States. |
